Good news! Shanxi Nuocheng Pharmaceutical Co., Ltd. obtained the production approval of fasudil hydrochloride raw materials and preparations.
Date:
2022-02-25
On November 24, 2021, the State Drug Administration announced the 115 drugs approved for listing, and Shanxi Nuocheng Pharmaceutical Co., Ltd.'s fasudil raw materials and injections were among them. This is another new achievement made by Norcheng Pharmaceutical. The landing of the new product approval not only reflects the overall strength of Norcheng Pharmaceutical in product research and development and registration, but also means that Norcheng Pharmaceutical's fasudil hydrochloride raw materials and injections will soon be sold domestically. Fasudil hydrochloride can improve and prevent cerebral vasospasm and cerebral ischemia after subarachnoid hemorrhage.
On November 24, 2021, the State Drug Administration announced the 115 drugs approved for listing, and Shanxi Nuocheng Pharmaceutical Co., Ltd.'s fasudil raw materials and injections were among them. This is another new achievement made by Norcheng Pharmaceutical. The landing of the new product approval not only reflects the overall strength of Norcheng Pharmaceutical in product research and development and registration, but also means that Norcheng Pharmaceutical's fasudil hydrochloride raw materials and injections will soon be sold domestically. Fasudil hydrochloride can improve and prevent cerebral vasospasm and cerebral ischemia after subarachnoid hemorrhage.
Key words:
Biopharmaceuticals
2023-07-02
Self-monitoring programme in 2023
2023-06-26